Terms: = Breast cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51
463 results:
1. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
Fehm T; Cottone F; Dunton K; André F; Krop I; Park YH; De Laurentiis M; Miyoshi Y; Armstrong A; Borrego MR; Yerushalmi R; Duhoux FP; Takano T; Lu W; Egorov A; Kim SB
Lancet Oncol; 2024 May; 25(5):614-625. PubMed ID: 38697155
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative breast cancer.
Sato K; Miura K; Tamori S; Akimoto K
Cancer Genomics Proteomics; 2024; 21(3):316-326. PubMed ID: 38670590
[TBL] [Abstract] [Full Text] [Related]
3. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
[TBL] [Abstract] [Full Text] [Related]
4. Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Santé cohort.
Sellem L; Srour B; Javaux G; Chazelas E; Chassaing B; Viennois E; Debras C; Druesne-Pecollo N; Esseddik Y; Szabo de Edelenyi F; Arnault N; Agaësse C; De Sa A; Lutchia R; Huybrechts I; Scalbert A; Pierre F; Coumoul X; Julia C; Kesse-Guyot E; Allès B; Galan P; Hercberg S; Deschasaux-Tanguy M; Touvier M
PLoS Med; 2024 Feb; 21(2):e1004338. PubMed ID: 38349899
[TBL] [Abstract] [Full Text] [Related]
5. Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer.
Gong X; Zheng C; Cai Y; Zhang W; Zhu B; Rong R; Kong Y; Zhang Y; Wang J; Li Y; Zhang P
J Control Release; 2024 Mar; 367():637-648. PubMed ID: 38295994
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of the accuracy of an augmented reality-based tumor-targeting guide for breast-conserving surgery.
Ock J; Moon S; Kim M; Ko BS; Kim N
Comput Methods Programs Biomed; 2024 Mar; 245():108002. PubMed ID: 38215659
[TBL] [Abstract] [Full Text] [Related]
7. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women.
Zirpoli GR; Pfeiffer RM; Bertrand KA; Huo D; Lunetta KL; Palmer JR
Breast Cancer Res; 2024 Jan; 26(1):2. PubMed ID: 38167144
[TBL] [Abstract] [Full Text] [Related]
8. breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
Yuk JS; Kim T; Cho H; Gwak G
Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
[TBL] [Abstract] [Full Text] [Related]
9. Assessing Fear of Thyroid cancer in the General U.S. Population: A Cross-Sectional Study.
Taylor SR; Chiu A; Hoxha I; Saucke MC; Jensen CB; Pitt SC
Thyroid; 2024 Feb; 34(2):234-242. PubMed ID: 38115606
[No Abstract] [Full Text] [Related]
10. Global research trends and prospects related to tumor microenvironment within Triple Negative breast cancer: a bibliometric analysis.
Li P; Li J; Tong X; Xiao Z; Diao W; Zhong C; Zhou J; Wu W
Front Immunol; 2023; 14():1261290. PubMed ID: 38111580
[TBL] [Abstract] [Full Text] [Related]
11. Association Between a History of breast cancer and Decreased Thyroid cancer-specific Mortality.
Lin S; Wang Z; Xing M
J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
[TBL] [Abstract] [Full Text] [Related]
12. breast cancer risk for the joint exposure to metals and metalloids in women: Results from the EPIC-Spain cohort.
Fernández-Martínez NF; Rodríguez-Barranco M; Huerta JM; Gil F; Olmedo P; Molina-Montes E; Guevara M; Zamora-Ros R; Jiménez-Zabala A; Colorado-Yohar SM; Ardanaz E; Bonet C; Amiano P; Chirlaque MD; Pérez-Gómez B; Jiménez-Moleón JJ; Martín-Jiménez M; de Santiago E; Sánchez MJ
Sci Total Environ; 2024 Feb; 912():168816. PubMed ID: 38036124
[TBL] [Abstract] [Full Text] [Related]
13. breast Imaging Patient Demographics at a Major Comprehensive cancer Center Before and During the COVID-19 Pandemic.
Cohen EO; Edelkamp P; Sun J; Leung JWT
J Am Coll Radiol; 2024 Apr; 21(4):576-588. PubMed ID: 37952808
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes: Systematic Review and Meta-analysis.
Waninger JJ; Ma VT; Chopra Z; Pearson AN; Green MD
Cancer J; 2023 Sep-Oct 01; 29(5):279-284. PubMed ID: 37796646
[TBL] [Abstract] [Full Text] [Related]
16. Audit of Sex and Gender Medicine Topics in Preclinical School of Medicine Curriculum.
Trieglaff K; Zamzow MJ; Sutherland B; Farkas A; Pfister S
WMJ; 2023 Sep; 122(4):243-249. PubMed ID: 37768763
[TBL] [Abstract] [Full Text] [Related]
17. Risk of cardiovascular disease in cancer survivors: A cohort study of 446,384 New Zealand primary care patients.
Tawfiq E; Pylypchuk R; Elwood JM; McKeage M; Wells S; Selak V
Cancer Med; 2023 Oct; 12(19):20081-20093. PubMed ID: 37746882
[TBL] [Abstract] [Full Text] [Related]
18. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
[TBL] [Abstract] [Full Text] [Related]
19. Second Primary cancer Among Patients With Papillary Thyroid Carcinoma Following the Chernobyl Disaster.
Taha A; Taha-Mehlitz S; Nadyrov EA; Zinovkin D; Veyalkin I; Levin L; Pranjol MZI; Melling N; Honaker MD; Cattin PC; Schmid RA
JAMA Netw Open; 2023 Aug; 6(8):e2329559. PubMed ID: 37589974
[TBL] [Abstract] [Full Text] [Related]
20. Optimization of an Information Leaflet to Influence Medication Beliefs in Women With breast cancer: A Randomized Factorial Experiment.
Green SMC; Hall LH; French DP; Rousseau N; Parbutt C; Walwyn R; Smith SG
Ann Behav Med; 2023 Oct; 57(11):988-1000. PubMed ID: 37494669
[TBL] [Abstract] [Full Text] [Related]
[Next]
